一般实践中老年澳大利亚人的虚弱查和管理:混合方法评估
Jennifer R Job1, Caroline Nicholson1, Ruby Strauss1
1Centre for Health System Reform and Integration, Mater Research-The University of Queensland, Level 8, Health Sciences Building, RBWH, Brisbane, 4006, Australia, 61 7 3365 5379.
Interactive journal of medical research
|March 12, 2026
概括
在年度健康评估中使用FRAIL尺度工具对老年澳大利亚人进行脆弱性查是可行的. 这种方法有助于识别脆弱个体,并促进主动管理,改善75岁以上人口的健康结果.
科学领域:
- 老年学是一门学科.
- 主要护理医学 医疗保健
- 公共卫生 公共卫生
背景情况:
- 脆弱性是老年人群不良健康结果的重要风险因素.
- 国际指导方针提倡在初级保健中进行脆弱性查,但在澳大利亚,这不是标准的做法.
- 早期识别和干预可以阻止或逆转脆弱性进展.
研究的目的:
- 调查75岁及以上澳大利亚人的虚弱程度.
- 评估脆弱性管理所需的资源.
- 在75+健康评估 (75+HA) 中确定实施脆弱性查和管理的决定因素.
主要方法:
- 在24个澳大利亚一般实践中进行了混合方法评估.
- 在75+HA.中整合了FRAIL (疲劳,抵抗,行走,疾病,减肥) 尺度工具.
- 收集的数据包括FRAIL分数,住院,干预,工作人员的看法以及与工作人员和患者的定性访谈.
主要成果:
- 在1484名被查的个人 (≥75岁) 中,有15%是脆弱的,脆弱的个人更有可能是女性,老年人和更多的药物.
- 虚弱的患者有较高的非选择性住院率,与虚弱和强壮的个人相比.
- 常见的管理建议包括药物审查,老年护理支持和运动;障碍包括健康,运输,成本和时间.
结论:
- 将FRAIL尺度工具集成到75+HA中,为初级保健中的积极脆弱性管理提供了资助的机会.
- 该工具因其简单性和易于集成而受到重视;软件集成将提高采用率.
- 需要在不同的环境中进行进一步的研究,包括土著和托雷斯海峡岛民人口,以改善脆弱性预防和管理.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
Pharmacodynamics in Geriatric Patients: Effects of Age
307
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
785
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
785


